Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ricin toxin is a highly potent cytotoxin and lectin produced in the seeds of the castor oil plant (Ricinus communis). It is a heterodimeric protein consisting of two chains: the A chain (RTA), an RNA N-glycosidase that enzymatically depurinates ribosomal RNA and irreversibly inhibits protein synthesis, and the B chain (RTB), a lectin that binds galactose-containing glycoproteins and facilitates entry of the toxin into cells. Upon cellular uptake by endocytosis, the A chain is released into the cytosol where it disables ribosomes and causes rapid cell death. Ricin is one of the most toxic naturally occurring substances and is classified as a type II ribosome-inactivating protein and a select agent due to its potential use as a biological weapon. There are currently no effective antidotes, and supportive care is the mainstay of treatment in cases of poisoning.
Inactivates ribosomes by depurinating a specific adenosine in the 28S rRNA, halting protein synthesis and leading to apoptosis/cell death
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ricin toxin.